FDA approves ranibizumab for the treatment of diabetic macular edema via continuous delivery implant
February 4th 2025Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a one-time, outpatient procedure, continuously delivering a customized formulation of ranibizumab over time.
New Opportunities in Topical Glaucoma Management
January 31st 2025A newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.
Dr. Susan Cotter receives global recognition with recent accolades
January 30th 2025Cotter, OD, MS, FAAO, was recognized with the Optometrist of the Year Award by Universitat Politècnica de Catalunya Faculty of Optics and Optometry of Terrassa, and as the 2024 UAB School of Optometry’s Springer Lecturer.